Population one-compartment pharmacokinetic analysis with missing dosage data

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 5, 2004, Pages 441-451

  Soy, Dolors ^a   Beal, Stuart L ^a,b   Sheiner, Lewis B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DOSE CALCULATION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FIRST PASS EFFECT; HUMAN; HUMAN EXPERIMENT; PRESCRIPTION; PRIORITY JOURNAL; RELIABILITY; SIMULATION;

ABSORPTION; ALGORITHMS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; HUMANS; MODELS, STATISTICAL; PHARMACOKINETICS; POPULATION; PRESCRIPTIONS, DRUG; REPRODUCIBILITY OF RESULTS;

EID: 7944220860     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.07.010     Document Type: Article

References (17)

1. W. Wang, F. Husan, S.C. Chow The impact of patient compliance on drug concentration profile in multiple doses Stat Med 15 1996 659 669
2. W. Wang, S. Ouyang The formulation of the principle of superposition in the presence of non-compliance and its applications in multiple dose pharmacokinetics J Pharmacokinet Biopharm 26 1998 457 469
3. P. Girard, L.B. Sheiner, H. Kastrissios, T.F. Blaschke Do we need full compliance data for population pharmacokinetic analysis? J Pharmacokinet Biopharm 24 1996 265 282
4. E.N. Jonsson, J.R. Wade, G. Almqvist, M.O. Karlsson Discrimination between rival dosing histories Pharm Res 14 1997 984 991
5. B. Vrijens, E. Goetghebeur The impact of compliance in pharmacokinetic studies Stat Methods Med Res 8 1999 247 262
6. Carroll RJ, Ruppert D, Stefanski L. Measurement error in nonlinear models. Monographs on statistics and applied probability. Vol. 63. London: Chapman & Hall; 1995.
7. J. Lu, J.-M. Gries, D. Verotta, L.B. Sheiner Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of noncompliance J Pharmacokinet Pharmacodyn 28 2001 343 362
8. M. Karlsson, E. Jonsson, C. Wiltse, J. Wade Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients J Pharmacokinet Biopharm 26 1998 207 246
9. Duffull S, Isbister G, Dawson A, Hackett L, Whyte I. Estimating population pharmacokinetic parameters when dose and dose-time are not known accurately. Population Approach Group in Europe (PAGE) Meeting; Verona, Italy; Session VIII, 2003 June 12-13.
10. Gibaldi M, Perrier D. Pharmacokinetics. In: Swarbrick J, editor. Drugs and the pharmaceutical sciences. Vol. 15. New York: Marcel Dekker; 1982. p. 1-43.
11. M. Stein Large sample properties of simulations using Latin hypercube sampling Technometrics 29 1987 143 151
12. A. Owen Controlling correlations in Latin hypercube samples J Am Stat Assoc 89 1994 1517 1522
13. Beal SL, Sheiner LB, editors. NONMEM users guides. Hanover (MD): GloboMax, LLC; 1989-98.
14. L.B. Sheiner, S.L. Beal Some suggestions for measuring predictive performance J Pharmacokinet Biopharm 9 1981 503 512
15. R. Newton, L.J. Broughton, M.J. Lind, P.J. Morrison, H.J. Rogers, I.D. Bradbrook Plasma and salivary pharmacokinetics of caffeine in man Eur J Clin Pharmacol 21 1981 45 52
16. J.A. Cramer, R.H. Mattson, M.L. Prevey, R.D. Scheyer, V.L. Ouellette How often is medication taken as prescribed? A novel assessment technique JAMA 261 1989 3273 3277
17. G. Levy A pharmacokinetic perspective on medicament noncompliance Clin Pharmacol Ther 54 1993 242 244